Norman Foster

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi request reprint Validating FDG-PET as a biomarker for frontotemporal dementia
    Norman L Foster
    Department of Neurology and Institute of Gerontology, University of Michigan, Ann Arbor, MI, USA
    Exp Neurol 184:S2-8. 2003
  2. doi request reprint Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Innovations in care that advance Alzheimer's disease drug development
    Norman L Foster
    Center for Alzheimer s Care, Imaging, and Research, Department of Neurology, University of Utah, Salt Lake City, UT, USA
    Alzheimers Dement 5:159-62. 2009
  3. doi request reprint Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer's disease
    Norman L Foster
    Center for Alzheimer s Care, Imaging and Research, Department of Neurology, University of Utah, Salt Lake City, UT, USA
    Alzheimers Dement 4:S29-36. 2008
  4. ncbi request reprint FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
    Norman L Foster
    Center for Alzheimer s Care, Imaging and Research and Department of Neurology, University of Utah, USA
    Brain 130:2616-35. 2007
  5. ncbi request reprint Adaptive Markov modeling for mutual-information-based, unsupervised MRI brain-tissue classification
    Suyash P Awate
    School of Computing, Scientific Computing and Imaging Institute, University of Utah, 50 South Central Campus Drive, Salt Lake City, UT 84112, USA
    Med Image Anal 10:726-39. 2006
  6. ncbi request reprint Quantifying metabolic asymmetry modulo structure in Alzheimer's disease
    P Thomas Fletcher
    School of Computing, University of Utah, Salt Lake City, UT, USA
    Inf Process Med Imaging 20:446-57. 2007
  7. ncbi request reprint A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging
    Roger Higdon
    University of Washington, Seattle, USA
    Stat Med 23:315-26. 2004
  8. pmc Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease
    Christian Habeck
    Taub Institute, Columbia University Medical Center, New York, NY 10032, USA
    Neuroimage 40:1503-15. 2008
  9. ncbi request reprint A new framework for the diagnosis of Alzheimer's disease
    Norman L Foster
    Lancet Neurol 6:667-9. 2007
  10. ncbi request reprint The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers
    John C Morris
    Washington University, St Louis, MO 63108, USA
    Alzheimer Dis Assoc Disord 20:210-6. 2006

Research Grants

  1. Pilot Collaborative PET Imaging Trial
    Norman Foster; Fiscal Year: 2005

Detail Information

Publications14

  1. ncbi request reprint Validating FDG-PET as a biomarker for frontotemporal dementia
    Norman L Foster
    Department of Neurology and Institute of Gerontology, University of Michigan, Ann Arbor, MI, USA
    Exp Neurol 184:S2-8. 2003
    ..Additional carefully designed clinical trials are needed to validate FDG-PET as a diagnostic biomarker...
  2. doi request reprint Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Innovations in care that advance Alzheimer's disease drug development
    Norman L Foster
    Center for Alzheimer s Care, Imaging, and Research, Department of Neurology, University of Utah, Salt Lake City, UT, USA
    Alzheimers Dement 5:159-62. 2009
    ..These innovations can simultaneously improve the translation of research advances, and benefit AD research...
  3. doi request reprint Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer's disease
    Norman L Foster
    Center for Alzheimer s Care, Imaging and Research, Department of Neurology, University of Utah, Salt Lake City, UT, USA
    Alzheimers Dement 4:S29-36. 2008
    ..The judicious use of FDG-PET is needed to accelerate the evaluation of promising new drugs and more rationally target treatments for dementing diseases...
  4. ncbi request reprint FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
    Norman L Foster
    Center for Alzheimer s Care, Imaging and Research and Department of Neurology, University of Utah, USA
    Brain 130:2616-35. 2007
    ..FDG-PET adds important information that appropriately increases diagnostic confidence, even among experienced dementia specialists...
  5. ncbi request reprint Adaptive Markov modeling for mutual-information-based, unsupervised MRI brain-tissue classification
    Suyash P Awate
    School of Computing, Scientific Computing and Imaging Institute, University of Utah, 50 South Central Campus Drive, Salt Lake City, UT 84112, USA
    Med Image Anal 10:726-39. 2006
    ..Combined with an atlas-based initialization, it is completely automatic. Experiments on real, simulated, and multimodal data demonstrate the advantages of the method over the current state-of-the-art...
  6. ncbi request reprint Quantifying metabolic asymmetry modulo structure in Alzheimer's disease
    P Thomas Fletcher
    School of Computing, University of Utah, Salt Lake City, UT, USA
    Inf Process Med Imaging 20:446-57. 2007
    ..We present results from applying the methodology to images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)...
  7. ncbi request reprint A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging
    Roger Higdon
    University of Washington, Seattle, USA
    Stat Med 23:315-26. 2004
    ..Methods using PLS appear to be more successful. Averaging or using VOI data may also be helpful...
  8. pmc Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease
    Christian Habeck
    Taub Institute, Columbia University Medical Center, New York, NY 10032, USA
    Neuroimage 40:1503-15. 2008
    ..Multivariate measures of AD utilize the covariance structure of imaging data and provide complementary, clinically relevant information that may be superior to univariate measures...
  9. ncbi request reprint A new framework for the diagnosis of Alzheimer's disease
    Norman L Foster
    Lancet Neurol 6:667-9. 2007
  10. ncbi request reprint The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers
    John C Morris
    Washington University, St Louis, MO 63108, USA
    Alzheimer Dis Assoc Disord 20:210-6. 2006
    ..Data obtained with the UDS are submitted to the National Alzheimer's Coordinating Center and represent a unique and valuable source of data to support and stimulate collaborative research...
  11. ncbi request reprint Mixed dementia: emerging concepts and therapeutic implications
    Kenneth M Langa
    Division of General Medicine, Department of Medicine, University of Michigan Medical School, Ann Arbor, USA
    JAMA 292:2901-8. 2004
    ..The prevalence of mixed dementia, defined as the coexistence of Alzheimer disease (AD) and vascular dementia (VaD), is likely to increase as the population ages...
  12. ncbi request reprint Out-of-pocket health care expenditures among older Americans with dementia
    Kenneth M Langa
    Division of General Medicine, Department of Medicine, University of Michigan Medical School, Ann Arbor, 48109 0429, USA
    Alzheimer Dis Assoc Disord 18:90-8. 2004
    ....
  13. ncbi request reprint Predicting nursing home admission: estimates from a 7-year follow-up of a nationally representative sample of older Americans
    Jane Banaszak-Holl
    Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, 48109 2029, USA
    Alzheimer Dis Assoc Disord 18:83-9. 2004
    ..Interventions for individuals with dementia should impact the behavioral aspects of the condition and slow disease progression in addition to improving physical functioning...
  14. ncbi request reprint Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials
    Michael Grundman
    Alzheimer s Disease Cooperative Study, Department of Neurosciences, University of California San Diego, 8950 Villa La Jolla Drive, Suite 227, La Jolla, CA 92037, USA
    Arch Neurol 61:59-66. 2004
    ..The Memory Impairment Study (MIS) is a multicenter clinical trial in patients with MCI designed to evaluate whether vitamin E or donepezil is effective at delaying the time to a clinical diagnosis of AD...

Research Grants3

  1. Pilot Collaborative PET Imaging Trial
    Norman Foster; Fiscal Year: 2005
    ..In addition to its scientific aims, this pilot trial also will evaluate subject selection and consensus panel procedures and uniform image acquisition and quality control methods needed for the large-scale study. ..